Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Pfizer · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
breastcancerbreastneoplasms
breast neoplasms, brca 1 gene mutation, brca 2 gene mutation, breast cancer, brca mutation, parp inhibitor, brca 1, brca 2, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 812612
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.